Domus Medicorum: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Domus Medicorum
Largest movements
- Cash -€3,707
down €3,707 (-10.2%), from €36,223 to €32,515
mainly Net result for the year (-€11,029) and Other debts (-€1,045)
- Tangible fixed assets -€2,420
down €2,420 (-3.1%), from €76,968 to €74,547
of which Land and buildings: -€1,734
- Profit (loss) carried forward -€11,029
down €11,029 (-36.9%), from -€29,916 to -€40,946
- Accrued charges and deferred income +€3,857
up €3,857 (+49.5%), from €7,790 to €11,647
- Trade debts +€2,089
up €2,089, from €0 to €2,089
- Gross operating margin -€2,097
down €2,097, from €1,334 to -€763
- Financial charges -€543
down €543 (-11.7%), from €4,634 to €4,091
- Financial income -€517
down €517 (-100%), from €517 to €0
- Depreciation +€343
up €343 (+16.5%), from €2,077 to €2,420
- Other operating charges +€245
up €245 (+7.0%), from €3,510 to €3,755
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €113,190 | €107,063 | -€6,128 | -5.4% |
| Fixed assets | 21/28 | €76,968 | €74,547 | -€2,420 | -3.1% |
| Tangible fixed assets | 22/27 | €76,968 | €74,547 | -€2,420 | -3.1% |
| Land and buildings | 22 | €76,281 | €74,547 | -€1,734 | -2.3% |
| Other tangible fixed assets | 26 | €686 | €0 | -€686 | -100% |
| Current assets | 29/58 | €36,223 | €32,515 | -€3,707 | -10.2% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €36,223 | €32,515 | -€3,707 | -10.2% |
| Total equity and liabilities | 10/49 | €113,190 | €107,063 | -€6,128 | -5.4% |
| Equity | 10/15 | €50,842 | €39,812 | -€11,029 | -21.7% |
| Contributions | 10/11 | €43,300 | €43,300 | = | 0.0% |
| Reserves | 13 | €37,458 | €37,458 | = | 0.0% |
| Non-distributable reserves | 130/1 | €8,422 | €8,422 | = | 0.0% |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Other | 1319 | €8,422 | €8,422 | = | 0.0% |
| Distributable reserves | 133 | €29,036 | €29,036 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€29,916 | -€40,946 | -€11,029 | -36.9% |
| Amounts payable | 17/49 | €62,349 | €67,250 | +€4,902 | +7.9% |
| Amounts payable within one year | 42/48 | €54,559 | €55,604 | +€1,045 | +1.9% |
| Trade debts | 44 | €0 | €2,089 | +€2,089 | |
| Suppliers | 440/4 | €0 | €2,089 | +€2,089 | |
| Other amounts payable | 47/48 | €54,559 | €53,514 | -€1,045 | -1.9% |
| Accrued charges and deferred income | 492/3 | €7,790 | €11,647 | +€3,857 | +49.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,077 | €2,420 | +€343 | +16.5% |
| Other operating charges | 640/8 | €3,510 | €3,755 | +€245 | +7.0% |
| Gross operating margin | 9900 | €1,334 | -€763 | -€2,097 | |
| Operating profit (loss) | 9901 | -€4,253 | -€6,939 | -€2,685 | -63.1% |
| Financial income | 75/76B | €517 | €0 | -€517 | -100% |
| Recurring financial income | 75 | €517 | €0 | -€517 | -100% |
| Financial charges | 65/66B | €4,634 | €4,091 | -€543 | -11.7% |
| Recurring financial charges | 65 | €4,634 | €4,091 | -€543 | -11.7% |
| Profit (loss) for the period before taxes | 9903 | -€8,370 | -€11,029 | -€2,660 | -31.8% |
| Profit (loss) for the period | 9904 | -€8,370 | -€11,029 | -€2,660 | -31.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€8,370 | -€11,029 | -€2,660 | -31.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.